TipRanks
Argent Biopharma (DE:H5O0)
FRANKFURT:H5O0
Germany Market
H5O0
Argent Biopharma
RESEARCH TOOLSreports

Argent Biopharma (H5O0) Income Statement

1 Followers

Argent Biopharma Income Statement

Last quarter (Q3 2025), Argent Biopharma's total revenue was AU$-5.16K, a decrease of -102.93% from the same quarter last year. In Q3, Argent Biopharma's net income was AU$-2.39M. See Argent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 161.19KAU$ 583.45KAU$ 891.08KAU$ 3.39MAU$ 4.73M
Gross Profit
AU$ -204.21KAU$ 446.32KAU$ 203.70KAU$ 1.45MAU$ 1.81M
Operating Expenses
AU$ 7.19MAU$ 15.89MAU$ 18.47MAU$ 17.05MAU$ 16.07M
Depreciation and Amortization
AU$ 164.59KAU$ 789.14KAU$ 1.29MAU$ 751.94KAU$ 405.22K
EBITDA
AU$ -7.23MAU$ -17.00MAU$ -15.77MAU$ -20.04MAU$ -16.54M
Operating Income
AU$ -7.39MAU$ -15.44MAU$ -18.26MAU$ -15.60MAU$ -14.26M
Other Income/Expenses
AU$ -316.66KAU$ -2.40MAU$ 713.39KAU$ -5.53MAU$ -2.88M
Pretax Income
AU$ -7.71MAU$ -17.84MAU$ -17.55MAU$ -21.13MAU$ -17.14M
Net Income
AU$ -7.71MAU$ -17.84MAU$ -17.53MAU$ -20.82MAU$ -16.77M
Per Share Metrics
Basic EPS
AU$ -0.09AU$ -0.31AU$ -0.47AU$ -7.10AU$ -6.50
Diluted EPS
AU$ -0.09AU$ -0.31AU$ -0.47AU$ -7.10AU$ -6.50
Weighted Average Shares Outstanding
 86.72M 57.17M 37.01M 2.94M 2.57M
Weighted Average Shares Outstanding (Diluted)
 86.72M 57.17M 37.01M 2.94M 2.57M
Currency in AUD

Argent Biopharma Earnings and Revenue History